COVID-19

Latest News

COVID-19. | Image Credit: Production Perig - stock.adobe.com
The Argument Against Routine Antibiotics for Patients With Nonsevere COVID-19

May 19th 2025

Over 500,000 US patients hospitalized with nonsevere COVID-19 saw no clinically significant benefit and potential harm associated with routine early antibiotic treatment, supporting antibiotic stewardship to limit unnecessary use.

Female health care employee suffering from burnout | Image Credit: D Lahoud/peopleimages.com - stock.adobe.com
Burnout Among Health Care Workers Drops Post Pandemic but Remains Elevated

April 21st 2025

World Health Organization headquarters | Image credit: hectorchristiaen - stock.adobe.com
WHO Members Draft Future Pandemic Agreement

April 16th 2025

COVID-19 | Image Credit: © blvdone-stock.adobe.com
Bias Reduction, Better Access Key to COVID-19 Equity Gains

April 14th 2025

Pediatric COVID. | Image Credit: Dmitry Naumov - stock.adobe.com
COVID-19 Linked to Increased Kidney Risks in Children

April 11th 2025

Continuing Medical Education
View All
May 22nd 2025

Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence

1.5 Credits / HIV/AIDS, Infectious Diseases

More News

Spotlights From Our Cochairs: Kashyap Patel, MD, Talks Value-Based Care, Effects of COVID-19 on Cancer Care Delivery
February 21st 2023

Spotlights From Our Cochairs: Kashyap Patel, MD, Talks Value-Based Care, Effects of COVID-19 on Cancer Care Delivery

Hayden E. Klein
Paul G. Alexander, MD, MPH.
February 15th 2023

Population Health Strategies to Advance Health Equity: A Q&A With Dr Paul G. Alexander

Matthew Gavidia Paul G. Alexander, MD, MPH
Paul G. Alexander, MD, MPH, executive vice president and chief health equity and transformation officer, RWJBarnabas Health, speaks on strategies his organization implemented during the COVID-19 pandemic to address continuity of care and communication challenges in underserved communities and further efforts to improve health equity.
ASH 2022: COVID-19
February 5th 2023

ASH 2022: COVID-19

Hayden E. Klein
Coverage from the 64th Annual American Society of Hematology Meeting and Exposition, December 10-13, 2022, New Orleans, Louisiana.
Interview with Dennis Scanlon, PhD
February 1st 2023

Dr Dennis Scanlon Discusses the Impact of the COVID-19 Pandemic on Medicaid Coverage

Justina Petrullo
With the public health emergency soon coming to an end, people covered by Medicaid will encounter new barriers, discusses Dennis Scanlon, PhD, professor of health policy and administration, Penn State University.
Washington DC
January 31st 2023

Biden to End COVID-19 National Emergencies in May

Allison Inserro
The Biden administration has said it would give 60 days notice before ending the public health emergency, which was set to end April 11, and the national emergency was set to end March 1.
WWR graphic
January 26th 2023

What We’re Reading: Affordable Care Act Update; COVID-19 Booster Effectiveness; Lawsuit Disputes Abortion Pill Ban

AJMC Staff
Affordable Care Act health care sign-ups are breaking records; updated COVID-19 boosters are proving successful against new variants; GenBioPro, which manufactures mifepristone, has filed suit regarding the constitutionality of a state abortion drug ban.
Image of a hospital entrance
January 17th 2023

Paxlovid May Reduce Already Low Risk of COVID-19 Hospitalization, Death Among Vaccinated Patients

Jaime Rosenberg
Patients who received nirmatrelvir plus ritonavir (Paxlovid) had lower risk of both hospitalization within 14 days and death within 28 days compared with patients who did not receive the treatment.
15 Things About the Diagnosis, Management, and Treatment of Long COVID
January 17th 2023

15 Things About the Diagnosis, Management, and Treatment of Long COVID

Allison Inserro
The most common symptoms of long COVID include fatigue, anxiety and depression, shortness of breath, sleep disturbances, and heart palpitations.
Image of a COVID-19 molecule
January 14th 2023

Prioritize Paxlovid for Unvaccinated Patients at High Risk of Severe COVID-19: Cost-effectiveness Analysis

Jaime Rosenberg
A new analysis has determined the cost-effectiveness of nirmatrelvir/ritonavir (Paxlovid), granted emergency use authorization by the FDA, across various scenarios of vaccination status and risk for severe disease.
Political Stance Does Not Overturn People’s Real-Life Perceptions on COVID-19, Study Finds
January 12th 2023

Political Stance Does Not Overturn People’s Real-Life Perceptions on COVID-19, Study Finds

Pearl Steinzor
A study found evidence to suggest that political opinion does not significantly shape people’s perceptions of the COVID-19 pandemic from a local standpoint.
What We're Reading: NYC Nursing Strike Ends; Hospital Volunteers and Labor Laws; Most Long COVID Symptoms Ease
January 12th 2023

What We're Reading: NYC Nursing Strike Ends; Hospital Volunteers and Labor Laws; Most Long COVID Symptoms Ease

AJMC Staff
Nurses in New York City reach agreement and end strike; hospitals benefiting from volunteer staff may be breaking labor laws; most lingering COVID symptoms will heal on its own, study finds.
What We’re Reading: Biden to Extend PHE Once More; High Court Rejects Pharma Suits; 988 Calls Soar
January 10th 2023

What We’re Reading: Biden to Extend PHE Once More; High Court Rejects Pharma Suits; 988 Calls Soar

AJMC Staff
President Joe Biden expected to renew COVID-19 public health emergency (PHE) one more time; Bristol Myers Squibb and Pfizer are denied by the Supreme Court; funding for the 988 mental health helpline expands inclusivity efforts.
What We’re Reading: SC, ID Courts Rule on Abortion; NIH Pilots COVID-19 Program; ADHD Drug Shortages Rise
January 6th 2023

What We’re Reading: SC, ID Courts Rule on Abortion; NIH Pilots COVID-19 Program; ADHD Drug Shortages Rise

AJMC Staff
State courts in South Carolina and Idaho ruled in opposite ways on abortion bans; virtual COVID-19 diagnostic and treatment launches in community; generic methylphenidate medication shortages negatively impact ADHD treatment.
Debra Delaney, MSN, FNP-BC, ChristianaCare
January 5th 2023

ChristianaCare’s Debra Delaney on the Importance of Mental Health Care Awareness

Maggie L. Shaw
There are still barriers to mental health care, in both the medical and outside worlds, noted Debra Delaney, MSN, FNP-BC, primary care nurse practitioner at ChristianaCare’s Helen F. Graham Cancer Center & Research Institute.
top 5 COVID-19 news of 2022
December 22nd 2022

Top 5 Most-Read COVID-19 News of 2022

AJMC Staff
2022's most-read news about the pandemic included the impact of COVID-19 on patients with asthma, the Biden administration's plans to advance vaccination and other initiatives, information about when SARS-CoV-2 is at its most infectious, and more.
graphic of money and stethoscope
December 14th 2022

Impact of COVID-19 Seen in 2021 National Health Care Expenditures Report

Allison Inserro
The effects of the COVID-19 pandemic were clear in the US national health care expenditure analysis of spending last year, as federal spending dropped, but health care use rebounded in 2021.
What We're Reading
December 8th 2022

What We’re Reading: ACA Marketplace Enrollment Rises; Vaccine Sharing Initiative May End; Tracking Opioid Overdoses

AJMC Staff
Approximately 5.5 million people have enrolled in health care coverage through the Affordable Care Act (ACA) marketplace for 2023; the Gavi alliance is debating the end of the worldwide vaccine sharing initiative; the White House is now tracking nonfatal opioid overdoses.
Contributor: COVID-19 Fell in Rank Among Telehealth Diagnoses Nationally in September 2022
December 6th 2022

Contributor: COVID-19 Fell in Rank Among Telehealth Diagnoses Nationally in September 2022

Robin Gelburd, JD
According to the most recent data from FAIR Health, COVID-19 telehealth diagnoses declined in 3 of the 4 census regions in the United States.
Samyukta Mullangi, MD, MBA, Memorial Sloan Kettering Cancer Center
December 1st 2022

Dr Samyukta Mullangi: COVID-19 Has Spurred Us to Ask How We Can Innovate Care Delivery

Maggie L. Shaw Mary Caffrey
During an Institute for Value-Based Medicine® event held in New York City, Samyukta Mullangi, MD, MBA, fellow in medical oncology at Memorial Sloan Kettering Cancer Center, discussed how disruptions from the COVID-19 pandemic are ushering in health care delivery reform.
Image of a hospital bed
November 26th 2022

Nirmatrelvir-Ritonavir Highly Effective at Preventing COVID-19 Hospitalization, RWE Says

Jared Kaltwasser
The study of real-world evidence (RWE) found nearly 9 in 10 patients in a highly vaccinated cohort avoided hospitalization within 15 days of treatment for COVID-19.
COVID-19
November 23rd 2022

Nirmatrelvir-Ritonavir Shows Safety, Efficacy in Real-world Study of High-risk COVID-19 Patients

Rose McNulty
The retrospective study evaluated outcomes in patients prescribed nirmatrelvir-ritonavir, as well as the management of drug interactions by clinical pharmacists prescribing the regimen.
covid-19
November 19th 2022

Researchers Point to IL-26 as Biomarker of Severe COVID-19

AJMC Staff
High levels of interleukin (IL)-26 levels correlate with an exaggerated inflammatory response that signifies severe cases of the disease, according to researchers.
Robin Gelburd
November 11th 2022

Contributor: COVID-19 Fell in Rank Among Telehealth Diagnoses in South and West in August 2022

Robin Gelburd, JD
Telehealth diagnoses in the South and West regions of the United States saw a reduction in COVID-19 diagnoses.
What We're Reading
November 10th 2022

What We’re Reading: Listeria Outbreak; COVID-19 Death Decline; Eli Lilly Pays in Drug Patent Trial

Julia Bonavitacola
A listeria outbreak has been linked to deli meats and cheeses; the World Health Organization announced that there has been a 90% drop in recent deaths in COVID-19 globally compared with 9 months ago; Eli Lilly was ordered to pay $176.5 million in a US migraine drug patent trial.
What We're Reading
November 8th 2022

What We’re Reading: VA to Prioritize Cancer Claims; Pfizer’s COVID-19 Cash; Medicaid Coverage Concerns

AJMC Staff
The Department of Veterans Affairs (VA) will give cancer claims priority when a new law takes effect in January 2023; Pfizer is looking to use its COVID-19 profits to grow other blockbusters; the probable loss of Medicaid coverage for millions next year is setting off debate.
Contributor: COVID-19 Ranked Among the Top 5 Telehealth Diagnoses Nationally in April 2022
July 6th 2022

Contributor: COVID-19 Ranked Among the Top 5 Telehealth Diagnoses Nationally in April 2022

Robin Gelburd, JD
COVID-19 was ranked in the top 5 diagnoses through telehealth in the Midwest, Northeast, and West regions as well as nationally in the month of April, coinciding with an increase in COVID-19 cases.
Population data.
June 24th 2022

What’s Next in Health Care? Panelists Highlight Data, Partnerships Post-COVID-19

Matthew Gavidia
Panelists of an AHIP 2022 session discussed how future policy, infrastructure, and investment strategies in public health will reinforce the efforts already made during the pandemic, with partnerships and engagement key to optimize innovation.
Robin Gelburd, JD
May 9th 2022

Contributor: COVID-19 Falls Out of Top 5 Telehealth Diagnoses in February 2022

Robin Gelburd, JD
The February drop out of the top 5 coincided with a sharp decline in new cases of COVID-19, as reported by the CDC, following the January peak of the wave of cases related to the Omicron variant.
EBO
February 14th 2022

Telehealth at Minnesota Oncology: Tackling COVID-19, Educating Patients, and Overcoming the Weather

Mary Caffrey
Rajini Katipamula-Malisetti, MD, a medical oncologist and hematologist with Minnesota Oncology who practices in Coon Rapids, has seen telehealth’s usefulness up close. During a pandemic, it can increase the number of touch points in areas such as survivorship care and nutrition, which would otherwise require a separate visit to the office.
Contributor: COVID-19 Among the Top 5 Telehealth Diagnoses in the US in November 2021
February 7th 2022

Contributor: COVID-19 Among the Top 5 Telehealth Diagnoses in the US in November 2021

Robin Gelburd, JD
<1234>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo